Preemption Redemption: FDA Legal Briefs Stand In For Product Liability Law
This article was originally published in The Gray Sheet
Executive Summary
FDA's new-found willingness to invoke the federal preemption doctrine in state tort suits may provide device firms with some solace in the absence of product liability reform legislation, but prospects remain unclear for non-original-PMA devices
You may also be interested in...
Riegel v. Medtronic At Supreme Court: Common Law Against Federal Statute
A major case impacting the medical device industry's vulnerability to product liability suits will land in the U.S. Supreme Court next month and legal scholars predict the outcome will be a close call
Riegel v. Medtronic At Supreme Court: Common Law Against Federal Statute
A major case impacting the medical device industry's vulnerability to product liability suits will land in the U.S. Supreme Court next month and legal scholars predict the outcome will be a close call
Supreme Court To Hear Medtronic Pre-emption Case, Despite Irregularities
The U.S. Supreme Court reaffirmed Oct. 1 that it will hear a case against Medtronic this session that could settle the long-standing issue of whether FDA premarket approval protects device manufacturers from liability in patient lawsuits